Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06216756 · ClinicalTrials.gov registry record · NA
Evaluating Cryopreserved Osteochondral Allograft Cores for the Treatment of Osteochondral Lesions in the Knee
A NA study of Osteochondral Defect, sponsored by AlloSource.
- Recruiting
- Registry status
- NA
- Development phase
- 68
- Enrollment target
- 6
- Study locations
NCT06216756: Recruiting NA study of Osteochondral Defect, sponsored by AlloSource.
NCT06216756 is a NA study of Osteochondral Defect that is actively recruiting participants, run by AlloSource. The registered enrollment target is 68 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06216756, a NA study of Osteochondral Defect, is actively recruiting participants, sponsored by AlloSource.
- RECRUITING
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
- 6
- Study locations
Study Summary
The primary objective of this study is to obtain evidence of the effectiveness of Cryopreserved Osteochondral Allograft Core in the treatment of osteochondral lesions on the femoral condyle.
Primary Outcome
Change of physical functioning and pain from baseline as assessed by the subjective International Knee Documentation Committee (IKDC) score. Scores are reported on a 0-100 scale, with low scores indicating worse outcomes and higher scores indicating better outcomes.
Conditions Studied
Interventions
- PROCEDURE osteochondral transplant on the femoral condyle
Study Locations (6)
California
- Cedars-Sinai Kerlan Jobe Institute - Los Angeles
- Stanford Medicine-Orthopaedics and Sports Medicine in Redwood City - Redwood City
- University of California San Francisco - San Francisco
Arizona
- Banner- University Medical Center- Phoenix Orthopedic and Sports Medicine Institute - Phoenix
Illinois
- Rush Copley Medical Center - Aurora
Kentucky
- University of Kentucky Research Foundation - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2024-12-01 |
| Est. Completion | 2031-03 |
| Phase | NA |
What NCT06216756 shows while recruiting
NCT06216756 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Osteochondral Defect appearing as the primary indexed condition, and to 1 intervention - of which osteochondral transplant on the femoral condyle is the first listed.
NCT06216756 lists 6 locations in 4 states (California, Arizona, Illinois).
Frequently Asked Questions
What is clinical trial NCT06216756 about?
NCT06216756 is a clinical study titled "Evaluating Cryopreserved Osteochondral Allograft Cores for the Treatment of Osteochondral Lesions in the Knee". The primary objective of this study is to obtain evidence of the effectiveness of Cryopreserved Osteochondral Allograft Core in the treatment of osteochondral lesions on the femoral condyle.
What is the current status of trial NCT06216756?
This trial is currently recruiting. It is a NA study. The enrollment target is 68 participants. The study started on 2024-12-01. Estimated completion is 2031-03.
What conditions does trial NCT06216756 study?
This clinical trial studies the following conditions: Osteochondral Defect.
What interventions are being tested in trial NCT06216756?
The interventions under investigation include: osteochondral transplant on the femoral condyle (PROCEDURE).
Who is sponsoring clinical trial NCT06216756?
This trial is sponsored by AlloSource, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06216756 being conducted?
This trial has 6 study locations across Arizona, California, Illinois, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteochondral Defect
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06216756's enrollment target sits among peer trials
68 1133rd of 2000 higher than 862 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI